FdaApplication
NDA 203469
Identifiers
- fda_app_no: NDA203469
Properties
| Property | Value |
|---|---|
| applicant_name | TAKEDA PHARMACEUTICALS USA INC |
| application_type | NDA |
| approval_date | 2012-12-14 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ICLUSIG | PONATINIB HYDROCHLORIDE | EQ 10MG BASE | TABLET;ORAL |
| ICLUSIG | PONATINIB HYDROCHLORIDE | EQ 15MG BASE | TABLET;ORAL |
| ICLUSIG | PONATINIB HYDROCHLORIDE | EQ 45MG BASE | TABLET;ORAL |
| ICLUSIG | PONATINIB HYDROCHLORIDE | EQ 30MG BASE | TABLET;ORAL |
4 products